Eric Michael, MD
Senior Director, Clinical Development
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Eric Michael, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:40 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06674577 · A Rollover Study to Evaluate the Long-Term Safety and Efficacy of AtaciceptVera Therapeutics, Inc. · enrolling by invitation · IgA Nephropathy (IgAN), Renal and Urinary Disorders, Berger Disease · study director
- Ph3NCT04716231 · Atacicept in Subjects With IgA NephropathyVera Therapeutics, Inc. · active not recruiting · IgA Nephropathy, Berger Disease · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:40 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.